AVEO Pharmaceuticals Received Notice From Novartis On Jun. 29th Of A Termination Of The AV-380 License Agreement Dated August 13, 2015; Termination Will Be Effective Aug. 28 And Will Not Impact Co.'s Cash Guidance
Benzinga Newsdesk